Clondalkin Group acquires Keller Crescent
International flexible and specialist packaging producer Clondalkin Group has acquired Keller Crescent, the largest independently owned producer of folding cartons, labels, inserts, outserts and other packaging components servicing the North American pharmaceutical and healthcare markets.
International flexible and specialist packaging producer Clondalkin Group has acquired Keller Crescent, the largest independently owned producer of folding cartons, labels, inserts, outserts and other packaging components servicing the North American pharmaceutical and healthcare markets.
Headquartered in Evansville, Indiana, Keller Crescent operates three main production plants in Evansville and Indianapolis, Indiana, and in Charlotte, North Carolina - all of which are primary locations for servicing the pharmaceutical and healthcare industry, which accounts for more than 90% of Keller Crescent's sales.
The acquisition expands Clondalkin's prominent pharmaceutical packaging supply position in North America. Keller Crescent joins other dedicated Clondalkin pharmaceutical supply companies, including Pharmagraphics, which operates four complementary production facilities in North Carolina, Connecticut and Puerto Rico.
In the European market, Clondalkin supplies the pharma sector from Pharmagraphics Guy in Cork and from Kenilworth Products in Dublin; several other Clondalkin operations located in the UK, Poland, Netherlands and Germany also supply the pharmaceutical and healthcare markets.
"This is a great strategic fit that creates a real packaging powerhouse to serve the pharmaceutical/healthcare packaging markets," said Tom Smythe, president of Keller Crescent. "Our geographic reach and production capacity has dramatically increased as a result of joining the Clondalkin Group. The acquisition opens an exciting phase of new opportunities for our management, employees and most particularly our customers."
"Completing the Keller Crescent acquisition is a very important step in enhancing Clondalkin's product portfolio, as it increases our pharmaceutical, healthcare, cosmetics/toiletries and personal care activities to almost 25% of our annual group sales," said Norbert McDermott, the Clondalkin Group ceo. "Keller Crescent complements our Pharmagraphics operations extremely well. Coupled with our European capabilities, Clondalkin now has the presence and experience to service this truly global market.